Xentuzumab Biosimilar - Research Grade

Human

IGF2ï؟½

5mg/ml

IgG1 - lambda2

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P01344

Blue ice

Insulin-like growth factor 2 (IGF2) promotes growth and survival signaling and is implicated in tumor proliferation studied across cancer and developmental biology research. This recombinant human IgG1 monoclonal is an unconjugated, non-therapeutic analog of xentuzumab directed against IGF2 and is supplied for research use only (RUO). It is purified to a low-endotoxin standard suitable for in vivo work and produced in scalable milligram to gram quantities for bulk and high-throughput laboratories. Applications include ligand-neutralization and binding assays, in vitro IGF-signaling screens, control reagents, and preclinical tumor models exploring growth-factor dependence.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks